AR223195A1 - Un procedimiento para la preparacion de acidos benzopiran y benzotiopiran-4-carboxilicos sustituidos por halogenos - Google Patents

Un procedimiento para la preparacion de acidos benzopiran y benzotiopiran-4-carboxilicos sustituidos por halogenos

Info

Publication number
AR223195A1
AR223195A1 AR278784A AR27878479A AR223195A1 AR 223195 A1 AR223195 A1 AR 223195A1 AR 278784 A AR278784 A AR 278784A AR 27878479 A AR27878479 A AR 27878479A AR 223195 A1 AR223195 A1 AR 223195A1
Authority
AR
Argentina
Prior art keywords
benzotiopyran
halogenes
benzopyran
procedure
preparation
Prior art date
Application number
AR278784A
Other languages
English (en)
Spanish (es)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of AR223195A1 publication Critical patent/AR223195A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D335/06—Benzothiopyrans; Hydrogenated benzothiopyrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/92—Naphthopyrans; Hydrogenated naphthopyrans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Pyrane Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AR278784A 1978-11-08 1979-11-06 Un procedimiento para la preparacion de acidos benzopiran y benzotiopiran-4-carboxilicos sustituidos por halogenos AR223195A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/959,023 US4210663A (en) 1978-11-08 1978-11-08 Halogen substituted benzopyran- and benzothiopyran-4-carboxylic acids

Publications (1)

Publication Number Publication Date
AR223195A1 true AR223195A1 (es) 1981-07-31

Family

ID=25501572

Family Applications (1)

Application Number Title Priority Date Filing Date
AR278784A AR223195A1 (es) 1978-11-08 1979-11-06 Un procedimiento para la preparacion de acidos benzopiran y benzotiopiran-4-carboxilicos sustituidos por halogenos

Country Status (16)

Country Link
US (1) US4210663A (enExample)
EP (1) EP0011426B1 (enExample)
JP (2) JPS6033433B2 (enExample)
KR (1) KR830001821B1 (enExample)
AR (1) AR223195A1 (enExample)
AT (1) AT366680B (enExample)
AU (1) AU513399B2 (enExample)
CA (1) CA1132584A (enExample)
DE (1) DE2965755D1 (enExample)
DK (1) DK153947C (enExample)
ES (1) ES485798A1 (enExample)
FI (1) FI71139C (enExample)
IE (1) IE49109B1 (enExample)
IL (1) IL58656A (enExample)
PT (1) PT70420A (enExample)
YU (1) YU41675B (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4305955A (en) * 1980-10-21 1981-12-15 Pfizer Inc. Carboxylic acid therapeutic agents
US4486428A (en) * 1982-03-16 1984-12-04 Pfizer Inc. Bicyclic benzo fused compounds
US4537920A (en) * 1983-08-18 1985-08-27 Ethyl Corporation 4H-1-benzopyrans and lubricant compositions containing same
US4551542A (en) * 1984-09-26 1985-11-05 Pfizer Inc. Regeneration of 6-fluoro-4-chromanone from 6-fluoro-4-ureidochroman-4-carboxylic acid
US4853410A (en) * 1986-01-17 1989-08-01 Pfizer Inc. Hydroxyacetic acid derivatives for the treatment of diabetic complications
DE3737195A1 (de) * 1987-11-03 1989-05-18 Bayer Ag Chromanderivate, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
US5039672A (en) * 1990-04-05 1991-08-13 Pfizer Inc. Heterocyclic compounds as aldose reductase inhibitors
DE69128477T2 (de) * 1990-07-27 1998-07-16 Chugai Seiyaku K.K., Tokio/Tokyo Benzopyranderivat
AU1256192A (en) * 1991-02-18 1992-09-15 Chugai Seiyaku Kabushiki Kaisha Hair growth stimulant
US5407897A (en) * 1993-03-03 1995-04-18 American Cyanamid Company Method for safening herbicides in crops using substituted benzopyran and tetrahydronaphthalene compounds
WO1999043315A1 (en) * 1998-02-25 1999-09-02 Shionogi & Co., Ltd. Therapeutic agent for complication of diabetes
US7288279B2 (en) * 2001-12-21 2007-10-30 Michael Foods Of Delaware, Inc. Formulated fried egg product
JP4742215B2 (ja) * 2003-06-23 2011-08-10 Jnc株式会社 クロマン化合物、この化合物を含有する液晶組成物およびこの液晶組成物を含有する液晶表示素子
JP5956920B2 (ja) 2012-12-14 2016-07-27 株式会社コガネイ 液体供給装置

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3821383A (en) * 1972-07-10 1974-06-28 Ayerst Mckenna & Harrison Compositions for and a method of treating diabetic complications

Also Published As

Publication number Publication date
ATA719279A (de) 1981-09-15
IL58656A0 (en) 1980-02-29
FI793487A7 (fi) 1980-05-09
EP0011426A1 (en) 1980-05-28
KR830001273A (ko) 1983-04-30
AU5258279A (en) 1980-05-15
FI71139C (fi) 1986-11-24
CA1132584A (en) 1982-09-28
AT366680B (de) 1982-04-26
US4210663A (en) 1980-07-01
PT70420A (de) 1979-12-01
DK153947C (da) 1989-02-20
ES485798A1 (es) 1980-10-01
KR830001821B1 (ko) 1983-09-12
JPS6113716B2 (enExample) 1986-04-15
FI71139B (fi) 1986-08-14
IE49109B1 (en) 1985-08-07
YU41675B (en) 1987-12-31
DK471079A (da) 1980-05-09
IE792136L (en) 1980-05-08
EP0011426B1 (en) 1983-06-22
JPS5585582A (en) 1980-06-27
DK153947B (da) 1988-09-26
JPS56103176A (en) 1981-08-18
DE2965755D1 (en) 1983-07-28
YU269779A (en) 1983-02-28
JPS6033433B2 (ja) 1985-08-02
AU513399B2 (en) 1980-11-27
IL58656A (en) 1983-06-15

Similar Documents

Publication Publication Date Title
ES494300A0 (es) Un procedimiento para la preparacion de carboxialquil-dipep-tidos
ES484097A0 (es) Un procedimiento para la preparacion de nuevos derivados de-4-anilinoquinazolinas
ES490214A0 (es) Un procedimiento para la preparacion de derivados de feneta-nolamina
ES487379A0 (es) Un procedimiento para la preparacion de nuevas benzamidas sustituidas
ES488678A0 (es) Un procedimiento para la preparacion de nuevos derivados he-terociclicos
ES485620A0 (es) Un procedimiento para la preparacion de derivados de diben- zopirano
MX149923A (es) Procedimiento para la obtencion de acidos arilpiruvicos
ES490213A0 (es) Un procedimiento para la preparacion de fenetanolaminas
MX5545E (es) Procedimiento para producir acidos tiometil delta3-cefem-4-carboxilicos 7-(substituido)amino-3-substituidos
ES492955A0 (es) Un procedimiento para la preparacion de nuevos acidos feni- lalcanoicos
ES493196A0 (es) Un procedimiento para la preparacion de fenil-quinolicidinas
AR222815A1 (es) Procedimiento para la preparacion de acidos(alfa-trifluorometil-mercapto-propionil)-pirrolidinil-o tiazolidinil-carboxilicos
ES489048A0 (es) Un procedimiento para la preparacion de derivados de hidan- toina
ES493544A0 (es) Un procedimiento para la preparacion de derivados de ciclo- hexadieno
AR225776A1 (es) Un procedimiento para la preparacion de acido 9-oxo-11 alfa-hidroxi-15-metanosulfonamido-16-genoxi-cis-5 w-omega-tetranor prostenoico
ES489119A0 (es) Un procedimiento para la preparacion de acido 6-cloro-alfa- metil-carbazol-2-acetico
ES494168A0 (es) Un procedimiento para la preparacion de acidos alfa-aril- propionicos
ES493200A0 (es) Un procedimiento para la preparacion de fenil-quinolicidinas
ES489646A0 (es) Un procedimiento para la preparacion de derivados de cefa- losporina
ES490617A0 (es) Un procedimiento para la preparacion de derivados de oxadia-zolotriazona
ES492557A0 (es) Un procedimiento para la preparacion de acido 3-tienilmalo- nico
ES490521A0 (es) Un metodo para la preparacion de pivaloximetilester de aci- dos 6-beta-amidinopenicilanicos
MX5587E (es) Un procedimiento para la preparacion de 2-cloro-4-etilamino-6-isopropilamino-s-triazina
ES486666A0 (es) Un procedimiento para la preparacion de carbetoxi-carbonila-mino-pirimidinas
ES490615A0 (es) Un procedimiento para la preparacion de derivados de oxadia-zolotriazona